DC
GILD icon

Diametric Capital’s Gilead Sciences GILD Stock Holding History

Diametric Capital’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$418K Buy
+3,310
New +$436K 0.04% 349
2024
Q4 		– Sell
-3,240
Closed -$272K – 373
2024
Q3 		$272K Buy
+3,240
New +$247K 0.13% 231
2019
Q3 		– Sell
-30,315
Closed -$2.05M – 114
2019
Q2 		$2.05M Buy
+30,315
New +$1.99M 1.3% 26
2019
Q1 		– Sell
-48,511
Closed -$3.03M – 112
2018
Q4 		$3.03M Buy
48,511
+880
+2% +$61.5K 2.34% 7
2018
Q3 		$3.68M Buy
+47,631
New +$3.6M 3.2% 2

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Diametric Capital's GILD Position: Q2 2026 in Review

Diametric Capital opened a new position in Gilead Sciences (GILD) in Q2 2026: 3,310 shares worth $418K. The stake represents 0.04% of the portfolio and ranks #349 among its holdings. This is a return to the name: Diametric Capital previously reported a position in GILD as recently as Q3 2024.

Diametric Capital first reported a position in GILD in Q3 2018 and has held it in 5 quarters since. The position peaked at $3.68M in Q3 2018. 2,278 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Diametric Capital held 3,310 shares of Gilead Sciences worth $418K as of Q2 2026.
  • Gilead Sciences was a new Diametric Capital position in Q2 2026.
  • Gilead Sciences made up 0.04% of Diametric Capital's portfolio in Q2 2026, its #349 holding.
  • Diametric Capital first reported a position in Gilead Sciences in Q3 2018 and has held it in 5 quarters since.
  • Diametric Capital's Gilead Sciences position peaked at $3.68M in Q3 2018.
  • 2,278 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Diametric Capital's 13F filing for Q2 2026, filed 14 Aug 2026.